Summary of Study ST001086
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000725. The data can be accessed directly via it's Project DOI: 10.21228/M8ZM3X This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001086 |
Study Title | Targeted GC-MS of SETD2 isogenic cell lines |
Study Summary | In this study, SETD2 null isogenic 38E/38F clones derived from 786-O cells were generated by zinc finger nucleases, and the cellular metabolic changes of 786-O (WT) and 38E/38F isogenic cell lines (n=3 per group) were analyzed by GC-MS-based targeted metabolomics. |
Institute | Arizona State University |
Department | College of Health Solutions |
Last Name | Liu |
First Name | Jingping |
Address | 13208 E. Shea Blvd, Scottsdale, AZ |
jliu381@asu.edu | |
Phone | 4802078529 |
Submit Date | 2018-10-24 |
Raw Data File Type(s) | d |
Analysis Type Detail | GC-MS |
Release Date | 2018-12-11 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000725 |
Project DOI: | doi: 10.21228/M8ZM3X |
Project Title: | Targeted metabolomics of SETD2 isogenic cell lines |
Project Summary: | SETD2, the histone methyltransferase responsible for the trimethylation of H3K36, is inactivated in approximately 10-32% of clear renal cell carcinoma (ccRCC) cases. To reveal the impact of SETD2 loss on metabolic alterations in ccRCC. In this study, SETD2 null isogenic 38E/38F clones derived from 786-O cells were generated by zinc finger nucleases, and the cellular metabolic changes were analyzed by GC-MS-based targeted metabolomics. |
Institute: | Arizona State University |
Department: | College of Health Solutions |
Last Name: | Liu |
First Name: | Jingping |
Address: | 13208 E. Shea Blvd, Scottsdale, AZ |
Email: | jliu381@asu.edu |
Phone: | 4802078529 |